Administrative Proceeding File No. 3-19410

Respondents

Tongli Pharmaceuticals (USA), Inc. Vansen Pharma, Inc.


Release Date	Release Number	Name of Document
Jan. 6, 2021	34-90855	Opinion of the Commission
Oct. 30, 2020	34-90293	Order to Show Cause
Sept. 3, 2019	34-86852	Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934


Release Date	Release Number	Other Release Numbers	Name of Document
Nov. 21, 2019			Division's Motion for Default Against Certain Respondents, Brief in Support, and Proposed Opinion and Orders of the Commission
Sept. 3, 2019			Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934
Oct. 30, 2020			Order to Show Cause
Jan. 6, 2021			Opinion of the Commission